Cory Rice - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Cory Rice

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Cerebrovascular Diseases (Basel, Switzerland)|August 30, 2017

Magnetic Resonance Imaging Susceptibility-Weighted Imaging Lesion and Contrast Enhancement May Represent Infectious Intracranial Aneurysm in Infective EndocarditisSung-Min Cho, Cory Rice, Robert J Marquardt, et al.

Journal of Medicinal Chemistry|January 2, 2025

Discovery of SMD-3236: A Potent, Highly Selective and Efficacious SMARCA2 Degrader for the Treatment of SMARC4-Deficient Human CancersLin Yang, Wenbin Tu, Lingying Leng, et al.

Journal of Medicinal Chemistry|November 21, 2024

Discovery of Potent, Highly Selective, and Efficacious SMARCA2 DegradersZhenwu Li, Lalgudi S Harikrishnan, Guozhang Xu, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Cerebrovascular Diseases (Basel, Switzerland)|August 30, 2017

Journal of Medicinal Chemistry|January 2, 2025

Discovery of SMD-3236: A Potent, Highly Selective and Efficacious SMARCA2 Degrader for the Treatment of SMARC4-Deficient Human CancersLin Yang, Wenbin Tu, Lingying Leng, et al.

Journal of Medicinal Chemistry|November 21, 2024

Discovery of Potent, Highly Selective, and Efficacious SMARCA2 DegradersZhenwu Li, Lalgudi S Harikrishnan, Guozhang Xu, et al.

Pageof 2